Secondary Cavitary Pulmonary Tuberculosis After Apatinib Treatment in Lung Squamous Cell Cancer

Am J Ther. 2020 May/Jun;27(3):e310-e312. doi: 10.1097/MJT.0000000000000976.
No abstract available

MeSH terms

  • Carcinoma, Squamous Cell* / drug therapy
  • Humans
  • Lung
  • Lung Neoplasms* / drug therapy
  • Protein Kinase Inhibitors* / adverse effects
  • Pyridines* / adverse effects
  • Tuberculosis, Pulmonary* / chemically induced

Substances

  • Protein Kinase Inhibitors
  • Pyridines
  • apatinib